Newsletter | August 4, 2025

08.04.25 -- STREAM Edition: Here's Where CDMOs Improve For Cell And Gene Therapy Customers?

Utilizing An Integrated Approach With High Producing Stable Pools

Webinar | Abzena

Explore how a CLD approach, combined with cutting-edge technologies, can drive program success and accelerate the development of protein-based therapeutics.

Selecting Container Closure Components: Extractables And Leachables

Webinar | West Pharmaceutical Services, Inc.

Primary packaging components require a thorough assessment to ensure safety and efficacy. Plan ahead and start your assessment early to mitigate your risks, delays, and out-of-pocket costs.

Transposase-Enabled CLD: From Transfection To High Titer With Ease

Webinar | KBI Biopharma

Gain insight into the benefits of a next-generation CLD platform that delivers consistent quality, scalable performance and flexible expression solutions tailored to the demands of complex molecules.

Here's Where CDMOs Improve For Cell And Gene Therapy Customers?

Video | Outsourced Pharma

Donna Rill, Chief Technology Officer, Triumvira Immunologics, has advice for CDMOs to improve their service to CGT customers, and conversely, where drug developers can improve as well.

Solving The Inhalation Puzzle: A CDMO's Guide To Dry Powder Development

Webinar | Lonza

Delve into the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.

Advanced Drug Delivery And Drug Device Combination Product Solutions

Video | PCI Pharma Services

Examine end-to-end injectable services, a comprehensive approach, and dedication to excellence that provide convenient, easy-to-use, patient-centric therapies.